Proposed FDA Regulatory Flexibilities Permit Primary Diagnosis with Inspirata’s Dynamyx Digital Pathology Solution
21 janv. 2021 15h58 HE | Inspirata, Inc.
Tampa, Florida, Jan. 21, 2021 (GLOBE NEWSWIRE) -- Cancer informatics and digital pathology provider Inspirata announced today that pandemic-related regulatory flexibilities issued by the U.S....
Biotricity.jpg
Biotricity Submitted 510(k) U.S. FDA Filing for Biotres
05 janv. 2021 08h00 HE | biotricity
REDWOOD CITY, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, announced today that it made a...
Biotricity.jpg
Biotricity Provides Quarter Update and Announces Continued Growth
01 sept. 2020 08h00 HE | biotricity
REDWOOD CITY, Calif., Sept. 01, 2020 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company, today announced record results in its...
Biotricity.jpg
Biotricity Receives FDA clearance for Bioflux Software II System
04 août 2020 08h00 HE | biotricity
REDWOOD CITY, Calif., Aug. 04, 2020 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company, today announced that it has received a 510(k)...
nescientific_rgb[1].jpg
Northeast Scientific Inc. Wins 510(k) for IVUS Catheter Reprocessing
23 juin 2020 11h38 HE | Northeast Scientific, Inc.
WATERBURY, Conn., June 23, 2020 (GLOBE NEWSWIRE) -- Northeast Scientific Inc., this week announced it has received FDA clearance for reprocessing the .014 Digital IVUS catheter. This is the second...
Biotricity.jpg
Biotricity Files a 510(k) Application for its Advanced ECG Analysis Software
13 févr. 2020 08h00 HE | biotricity
REDWOOD CITY, Calif., Feb. 13, 2020 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company, announced today that it has filed a 510(k)...
Biotricity.jpg
Biotricity Completes Development of its ECG Patch Platform
04 déc. 2019 08h00 HE | biotricity
REDWOOD CITY, Calif., Dec. 04, 2019 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company, today announced that it has completed...
Bio-Sig-Logo-horiz.jpg
BioSig Technologies Issues Shareholder Letter
11 sept. 2018 08h00 HE | BioSig Technologies, Inc.
Santa Monica, CA, Sept. 11, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB:BSGM, OTCQB:BSGMD) a medical device company developing a proprietary biomedical signal processing platform...
BioSig Technologies Announces FDA 510(k) Clearance for PURE EP System
14 août 2018 08h07 HE | BioSig Technologies, Inc.
Santa Monica, CA, Aug. 14, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), announced that the Company has received 510(k) clearance for its first product, PURE EP System, from...
Biotricity.jpg
Biotricity Achieves FDA 510(k) Clearance for its Bioflux Device
18 déc. 2017 08h00 HE | biotricity
REDWOOD CITY, Calif., Dec. 18, 2017 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric...